Cooperation Agreement with Emmanuelle Charpentier's Laboratory

Posted on February 01, 2017

Today we signed a cooperation agreement with Prof. Dr. Emmanuelle Charpentier.

We are looking forward to this great partnership.

Prof. Dr. Emmanuelle Charpentiers

Prof. Dr. Emmanuelle Charpentier is best known for her role in deciphering the molecular mechanisms of the bacterial CRISPR-Cas9 immune system and repurposing it into a tool for genome editing. In particular she uncovered the mechanism beyond the maturation of non-coding RNA key for the CRISPR-Cas9 function. In collaboration with Jennifer Doudna's laboratory, Charpentier's laboratory showed that Cas9 could be used to make cuts in any DNA sequence desired. The method they developed involved the combination of Cas9 with easily created synthetic "guide RNA" molecules. Researchers worldwide have employed this method successfully to edit the DNA sequences of plants, animals, and laboratory cell lines.

Please accept marketing-cookies to watch this video.

Sources: Picture and text from; Video from (DFG channel)

Share this article

Receive updates about NGS articles and trainings

More news from ecSeq

On our blog you will find major news, background stories and press releases.

More frequent updates are provided on the following pages: